Clinical Trials Browser

Interventional × Pancreatic Neoplasms × trastuzumab deruxtecan × Clear all

NCT05417594 2026-06-02

CERTIS1

Phase 1/2 Recruiting

BreastCNSGastrointestinalGenitourinaryGynecologic

Astrocytoma, Breast Neoplasms, Fallopian Tube Neoplasms, Glioma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT07619521 2026-06-02

Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a, for Advanced Pancreatic Ductal Adenocarcinoma

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT04482309 2026-04-09

DPT02

Phase 2 Active not recruiting

477 enrolled 1 FDA

Gastrointestinal

Pancreatic Neoplasms, Colorectal Neoplasms